Silverfin false false 31/01/2025 01/02/2024 31/01/2025 Michael Considine 04/01/2024 14 January 2026 The principal activity of the company during the year was that of the provision of products and services for harm reduction services. 15386214 2025-01-31 15386214 bus:Director1 2025-01-31 15386214 core:CurrentFinancialInstruments 2025-01-31 15386214 core:ShareCapital 2025-01-31 15386214 core:RetainedEarningsAccumulatedLosses 2025-01-31 15386214 core:RemainingRelatedParties core:CurrentFinancialInstruments 2025-01-31 15386214 bus:OrdinaryShareClass1 2025-01-31 15386214 2024-02-01 2025-01-31 15386214 bus:FilletedAccounts 2024-02-01 2025-01-31 15386214 bus:SmallEntities 2024-02-01 2025-01-31 15386214 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 15386214 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 15386214 bus:Director1 2024-02-01 2025-01-31 15386214 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15386214 (England and Wales)

# ONE-USE HARM REDUCTION PRODUCTS LTD.

### Unaudited Financial Statements
For the financial period ended 31 January 2025
Pages for filing with the registrar

ONE-USE HARM REDUCTION PRODUCTS LTD.

## Unaudited Financial Statements

For the financial period ended 31 January 2025

Contents

ONE-USE HARM REDUCTION PRODUCTS LTD.

## STATEMENT OF FINANCIAL POSITION

As at 31 January 2025
ONE-USE HARM REDUCTION PRODUCTS LTD.

## STATEMENT OF FINANCIAL POSITION (continued)

As at 31 January 2025

| Note | 2025
|  | £
Current assets |  |
Debtors | 3 | 65,382
Cash at bank and in hand |  | 9,197
|  | 74,579
Creditors: amounts falling due within one year | 4 | ( 60,296)
Net current assets |  | 14,283
Total assets less current liabilities |  | 14,283
Net assets |  | 14,283
Capital and reserves |  |
Called-up share capital | 5 | 1,000
Profit and loss account |  | 13,283
Total shareholder's funds |  | 14,283

For the financial period ending 31 January 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The member has not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of One-use Harm Reduction Products Ltd. (registered number: 15386214) were approved and authorised for issue by the Director on 14 January 2026. They were signed on its behalf by:

Michael Considine Director |

ONE-USE HARM REDUCTION PRODUCTS LTD.

## NOTES TO THE FINANCIAL STATEMENTS

For the financial period ended 31 January 2025
ONE-USE HARM REDUCTION PRODUCTS LTD.

## NOTES TO THE FINANCIAL STATEMENTS

For the financial period ended 31 January 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

##### General information and basis of accounting

One-use Harm Reduction Products Ltd. (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

##### Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

##### Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

##### Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

##### Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

##### Ordinary share capital

The ordinary share capital of the Company is presented as equity.

#### 2. Employees

| 2025
| Number
Monthly average number of persons employed by the Company during the period, including the director | 1

#### 3. Debtors

| 2025
| £
Trade debtors | 529
Amounts owed by associates | 56,756
Amounts owed by related parties | 7,097
Other debtors | 1,000
| 65,382

#### 4. Creditors: amounts falling due within one year

| 2025
| £
Taxation and social security | 56,046
Other creditors | 4,250
| 60,296

#### 5. Called-up share capital

| 2025
| £
Allotted, called-up and fully-paid |
1,000 Ordinary shares of £ 1.00 each | 1,000

#### 6. Related party transactions

Transactions with the entity's director

| 2025
| £
Amounts due from the Director | 1,000

Other related party transactions

| 2025
| £
Amounts owed from a company under common control | 56,756
Amount owed to related party | 7,097